Comparative Study of Fractional CO2 Laser with Topical 1% Terbinafine Cream versus Oral Itraconazole in the Management of Onychomycosis
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.202 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Puranik S und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Onychomycosis is a common fungal infection of the nail unit caused by dermatophytes, yeasts and non-dermatophyte moulds. Oral itraconazole is an effective systemic antifungal agent, but adverse effects, drug interactions and contraindications may limit its use. Fractional carbon dioxide laser combined with topical antifungal therapy has emerged as a useful alternative because it can produce photothermal fungal damage and improve topical drug penetration through the nail plate. Materials and Methods: This hospital-based comparative interventional study included 40 adults with clinically diagnosed and microbiologically confirmed onychomycosis. Patients were allocated into two equal groups of 20 each. Group A received fractional CO2 laser therapy along with topical 1% terbinafine cream twice daily, while Group B received oral itraconazole 200 mg twice daily for one week per month for three months. Disease severity was assessed using the Onychomycosis Severity Index (OSI) at baseline and at six months.
Results
The mean age of the study population was 43.84 ± 13.39 years. A total of 93 affected nails were analysed, including 39 nails in the fractional CO2 laser group and 54 nails in the itraconazole group. Toenail involvement was the commonest pattern in both groups. Distal lateral subungual onychomycosis was the most frequent clinical type, accounting for 76.3% of affected nails. The mean baseline OSI was comparable between Group A and Group B (17.05 ± 9.64 versus 16.90 ± 9.56; p=0.941). At six months, the mean OSI reduced to 8.32 ± 9.70 in Group A and 9.52 ± 9.73 in Group B. The mean reduction in OSI was greater in the fractional CO2 laser group than in the itraconazole group (8.73 ± 7.04 versus 7.38 ± 6.61), but the difference was not statistically significant (p=0.345). No serious adverse event was observed in either group.
Conclusion
Fractional CO2 laser combined with topical 1% terbinafine cream and oral itraconazole pulse therapy were both effective in reducing onychomycosis severity. Although the fractional CO2 laser group showed a slightly greater OSI reduction and better tolerability, the intergroup difference was not statistically significant. Fractional CO2 laser with topical terbinafine may be considered a promising treatment option, especially for patients in whom systemic antifungal therapy is contraindicated or poorly tolerated.
Zitieren
APA
S, P., R, K., & C, H. K. (2026). Comparative Study of Fractional CO2 Laser with Topical 1% Terbinafine Cream versus Oral Itraconazole in the Management of Onychomycosis. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.202
Vancouver
S P, R K, C HK. Comparative Study of Fractional CO2 Laser with Topical 1% Terbinafine Cream versus Oral Itraconazole in the Management of Onychomycosis. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.202
BibTeX
@article{S2026,
author = {S, Puranik and R, Kumar and C, Herakal K.},
title = {Comparative Study of Fractional CO2 Laser with Topical 1% Terbinafine Cream versus Oral Itraconazole in the Management of Onychomycosis},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.202}
}
EUVIMED